NSE · VALIANTLAB
Valiant Laboratories Limited
₹82.41
+4.99%
Market Cap
447.59 Cr
P/E Ratio
-161.59
P/B Ratio
1.44
ROE
-1.05%
ROCE
0.78%
Dividend Yield
—
52W High
₹94.95
52W Low
₹56.53
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 |
|---|---|---|
| Revenue | 115.29 Cr | 91.98 Cr |
| Net Profit | 21.10 Cr | 1.76 Cr |
| EPS | 3.89 | 0.32 |
| Operating Profit | 27.26 Cr | 2.06 Cr |
Shareholding pattern
Promoter
74.94%
Public
25.06%
FII
—
DII
—
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 18 Jul 2025 | Rights | Rights 1:4 @ Premium Rs 65/- |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.